| Year |
Citation |
Score |
| 2023 |
Rupenthal ID, Agarwal P. Progress in Ocular Drug Delivery: Challenges and Constraints. Handbook of Experimental Pharmacology. PMID 37620616 DOI: 10.1007/164_2023_693 |
0.405 |
|
| 2023 |
Agarwal P, Rupenthal ID. Non-aqueous formulations in topical ocular drug delivery - A paradigm shift? Advanced Drug Delivery Reviews. 198: 114867. PMID 37178927 DOI: 10.1016/j.addr.2023.114867 |
0.417 |
|
| 2023 |
Li H, Dai F, Liu H, Tao Q, Hu J, Zhang Y, Xiao Z, Rupenthal ID, Li H, Yang F, Li W, Lin H, Hou D. Physicochemical properties and micro-interaction between micro-nanoparticles and anterior corneal multilayer biological interface film for improving drug delivery efficacy: the transformation of tear film turnover mode. Drug Delivery. 30: 2184312. PMID 36866574 DOI: 10.1080/10717544.2023.2184312 |
0.379 |
|
| 2022 |
Hu J, Li H, Zhao Y, Ke Y, Rupenthal ID, Liu H, Ye J, Han X, Yang F, Li W, Lin H, Hou D. Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction. International Journal of Nanomedicine. 17: 5915-5931. PMID 36506343 DOI: 10.2147/IJN.S382968 |
0.405 |
|
| 2021 |
Agarwal P, Behera S, Rupenthal ID. Ocular Distribution of Papaverine Using Non-aqueous Vehicles. Aaps Pharmscitech. 22: 160. PMID 34031787 DOI: 10.1208/s12249-021-02050-6 |
0.406 |
|
| 2021 |
Zidan G, Greene CA, Etxabide A, Rupenthal ID, Seyfoddin A. Gelatine-based drug-eluting bandage contact lenses: effect of PEGDA concentration and manufacturing technique. International Journal of Pharmaceutics. 120452. PMID 33676990 DOI: 10.1016/j.ijpharm.2021.120452 |
0.373 |
|
| 2021 |
Agarwal P, Craig JP, Rupenthal ID. Formulation Considerations for the Management of Dry Eye Disease. Pharmaceutics. 13. PMID 33546193 DOI: 10.3390/pharmaceutics13020207 |
0.347 |
|
| 2020 |
Han X, Zhao Y, Liu H, Li H, Liu S, Rupenthal ID, Yang F, Lv Z, Chen Y, Zang L, Li W, Ping Q, Tao Q, Hou D. Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles. Colloids and Surfaces. B, Biointerfaces. 197: 111355. PMID 33010720 DOI: 10.1016/j.colsurfb.2020.111355 |
0.344 |
|
| 2020 |
Thakur SS, Shenoy SK, Soo Suk J, Hanes JS, Rupenthal ID. Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 31981693 DOI: 10.1016/J.Ejpb.2020.01.008 |
0.346 |
|
| 2019 |
Rupenthal ID, Daugherty AL. Ocular drugs and drug delivery systems - Current trends and future perspectives. Drug Discovery Today. PMID 31330186 DOI: 10.1016/j.drudis.2019.07.005 |
0.342 |
|
| 2019 |
Agarwal P, Craig JP, Krösser S, Eickhoff K, Swift S, Rupenthal ID. Topical semifluorinated alkane based azithromycin suspension for the management of ocular infections. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 31195132 DOI: 10.1016/j.ejpb.2019.06.008 |
0.345 |
|
| 2019 |
Huang D, Chen YS, Rupenthal ID. Corrigendum to "Overcoming ocular drug delivery barriers through the use of physical forces" [Advanced Drug Delivery Reviews 126 (2018) 96-112]. Advanced Drug Delivery Reviews. PMID 31133328 DOI: 10.1016/j.addr.2019.05.006 |
0.344 |
|
| 2019 |
Agban Y, Thakur SS, Mugisho OO, Rupenthal ID. Depot formulations to sustain periocular drug delivery to the posterior eye segment. Drug Discovery Today. PMID 30930148 DOI: 10.1016/j.drudis.2019.03.023 |
0.448 |
|
| 2019 |
Agarwal P, Khun D, Krösser S, Eickhoff K, Wells FS, Willmott GR, Craig JP, Rupenthal ID. Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics. The Ocular Surface. PMID 30831252 DOI: 10.1016/j.jtos.2019.02.010 |
0.305 |
|
| 2019 |
Thakur SS, Chen YS, Houston ZH, Fletcher N, Barnett NL, Thurecht KJ, Rupenthal ID, Parekh HS. Ultrasound-Responsive Nanobubbles for Enhanced Intravitreal Drug Migration: an Ex Vivo Evaluation. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 30660691 DOI: 10.1016/j.ejpb.2019.01.014 |
0.357 |
|
| 2018 |
Thrimawithana TR, Rupenthal ID, Raesch SS, Lim JC, Morton JD, Bunt CR. Drug delivery to the lens for the management of cataracts. Advanced Drug Delivery Reviews. PMID 29604375 DOI: 10.1016/j.addr.2018.03.009 |
0.33 |
|
| 2018 |
Huang D, Chen YS, Green CR, Rupenthal ID. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia. Biomaterials. 168: 10-23. PMID 29597134 DOI: 10.1016/j.biomaterials.2018.03.034 |
0.325 |
|
| 2018 |
Uppalapati D, Sharma M, Aqrawe Z, Coutinho F, Rupenthal ID, Boyd BJ, Travas-Sejdic J, Svirskis D. Micelle Directed Chemical Polymerization of Polypyrrole Particles for the Electrically Triggered Release of Dexamethasone Base and Dexamethasone Phosphate. International Journal of Pharmaceutics. PMID 29581065 DOI: 10.1016/J.Ijpharm.2018.03.039 |
0.336 |
|
| 2018 |
Huang D, Chen YS, Xu Q, Hanes J, Rupenthal ID. Effects of enzymatic degradation on dynamic mechanical properties of the vitreous and intravitreal nanoparticle mobility. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 118: 124-133. PMID 29574081 DOI: 10.1016/j.ejps.2018.03.023 |
0.301 |
|
| 2018 |
Agarwal P, Scherer D, Günther B, Rupenthal ID. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs. International Journal of Pharmaceutics. PMID 29339249 DOI: 10.1016/j.ijpharm.2018.01.019 |
0.42 |
|
| 2017 |
Mahboobian MM, Seyfoddin A, Rupenthal ID, Aboofazeli R, Foroutan SM. Formulation Development and Evaluation of the Therapeutic Efficacy of Brinzolamide Containing Nanoemulsions. Iranian Journal of Pharmaceutical Research : Ijpr. 16: 847-857. PMID 29201076 |
0.402 |
|
| 2017 |
Huang D, Chen YS, Rupenthal ID. Overcoming ocular drug delivery barriers through the use of pHysical forces. Advanced Drug Delivery Reviews. PMID 28916492 DOI: 10.1016/j.addr.2017.09.008 |
0.408 |
|
| 2017 |
Zidan G, Rupenthal ID, Greene C, Seyfoddin A. Medicated Ocular Bandages and Corneal Health: Potential Excipients and Active Pharmaceutical Ingredients. Pharmaceutical Development and Technology. 1-11. PMID 28875742 DOI: 10.1080/10837450.2017.1377232 |
0.335 |
|
| 2017 |
Rupenthal ID. Drug-device combination approaches for delivery to the eye. Current Opinion in Pharmacology. 36: 44-51. PMID 28843865 DOI: 10.1016/j.coph.2017.08.003 |
0.409 |
|
| 2017 |
Thakur SS, Solloway J, Stikkelman A, Seyfoddin A, Rupenthal ID. Phase transition of a microemulsion upon addition of cyclodextrin - applications in drug delivery. Pharmaceutical Development and Technology. 1-28. PMID 28828910 DOI: 10.1080/10837450.2017.1371191 |
0.307 |
|
| 2017 |
Huang D, Chen YS, Rupenthal ID. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 28602870 DOI: 10.1016/j.ejpb.2017.06.009 |
0.371 |
|
| 2017 |
Bisht R, Jaiswal JK, Rupenthal ID. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye. Medical Hypotheses. 103: 5-9. PMID 28571808 DOI: 10.1016/j.mehy.2017.03.033 |
0.395 |
|
| 2017 |
Bisht R, Mandal A, Jaiswal JK, Rupenthal ID. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 28425224 DOI: 10.1002/Wnan.1473 |
0.51 |
|
| 2017 |
Mandal A, Bisht R, Rupenthal ID, Mitra AK. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28087407 DOI: 10.1016/J.Jconrel.2017.01.012 |
0.498 |
|
| 2016 |
Huang D, Chen YS, Rupenthal ID. Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the Retina. Molecular Pharmaceutics. PMID 27997199 DOI: 10.1021/acs.molpharmaceut.6b01029 |
0.314 |
|
| 2016 |
Rupenthal ID, O'Rourke M. Ocular drug delivery-eye on innovation. Drug Delivery and Translational Research. 6: 631-633. PMID 27766597 DOI: 10.1007/s13346-016-0335-6 |
0.416 |
|
| 2016 |
Bisht R, Mandal A, Rupenthal ID, Mitra AK. Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS. Drug Delivery and Translational Research. PMID 27371395 DOI: 10.1007/S13346-016-0308-9 |
0.303 |
|
| 2016 |
Agarwal P, Rupenthal ID. Modern approaches to the ocular delivery of cyclosporine A. Drug Discovery Today. PMID 27080149 DOI: 10.1016/j.drudis.2016.04.002 |
0.374 |
|
| 2016 |
Bisht R, Jaiswal JK, Chen YS, Jin J, Rupenthal ID. Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye. Expert Opinion On Drug Delivery. PMID 26967153 DOI: 10.1517/17425247.2016.1163334 |
0.437 |
|
| 2016 |
Ramtin A, Seyfoddin A, Coutinho F, Waterhouse G, Rupenthal I, Svirskis D. Cytotoxicity considerations and electrically tunable release of dexamethasone from polypyrrole for the treatment of back-of-the-eye conditions. Drug Delivery and Translational Research. 6: 793-799. PMID 26887593 DOI: 10.1007/S13346-016-0284-0 |
0.339 |
|
| 2016 |
Duxfield L, Sultana R, Wang R, Englebretsen V, Deo S, Swift S, Rupenthal I, Al-Kassas R. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery. Pharmaceutical Development and Technology. 21: 172-9. PMID 26794936 DOI: 10.3109/10837450.2015.1091839 |
0.39 |
|
| 2016 |
Agarwal P, Rupenthal ID. In vitro and ex vivo corneal penetration and absorption models. Drug Delivery and Translational Research. PMID 26762419 DOI: 10.1007/s13346-015-0275-6 |
0.343 |
|
| 2016 |
Agarwal P, Scherer D, Günther B, Rupenthal I. Semi-fluorinated alkanes for topical delivery of Cyclosporine Acta Ophthalmologica. 94. DOI: 10.1111/J.1755-3768.2016.0686 |
0.364 |
|
| 2015 |
Duxfield L, Sultana R, Wang R, Englebretsen V, Deo S, Rupenthal ID, Al-Kassas R. Ocular delivery systems for topical application of anti-infective agents. Drug Development and Industrial Pharmacy. 1-11. PMID 26325119 DOI: 10.3109/03639045.2015.1070171 |
0.314 |
|
| 2015 |
Chen YS, Green CR, Danesh-Meyer HV, Rupenthal ID. Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 25676338 DOI: 10.1016/j.ejpb.2015.01.031 |
0.313 |
|
| 2014 |
Chen Y, Green CR, Wang K, Danesh-Meyer HV, Rupenthal ID. Sustained intravitreal delivery of connexin43 mimetic peptide by poly(d,l-lactide-co-glycolide) acid micro- and nanoparticles - Closing the gap in retinal ischaemia. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 25497487 DOI: 10.1016/j.ejpb.2014.12.005 |
0.321 |
|
| 2014 |
Yasin MN, Svirskis D, Seyfoddin A, Rupenthal ID. Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems. Journal of Controlled Release : Official Journal of the Controlled Release Society. 196: 208-21. PMID 25307997 DOI: 10.1016/j.jconrel.2014.09.030 |
0.398 |
|
| 2013 |
Rupenthal I, Chen YS, Teague R, Perrett J, Danesh-Meyer H, Toth I, Green C. Modified connexin43 mimetic peptide shows higher efficacy in reducing retinal ganglion cell loss and vessel leak after retinal ischemia Acta Ophthalmologica. 91: 0-0. DOI: 10.1111/J.1755-3768.2013.1744.X |
0.371 |
|
| 2011 |
Rupenthal ID, Green CR, Alany RG. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: Physicochemical characterisation and in vitro release International Journal of Pharmaceutics. 411: 69-77. PMID 21453762 DOI: 10.1016/j.ijpharm.2011.03.042 |
0.332 |
|
| 2008 |
Franke S, Malcolmson C, Bunt CR, Rupenthal I, Alany RG. Imaging Techniques and their Role in Dosage form Design and Drug Delivery Research Current Pharmaceutical Analysis. 4: 118-125. DOI: 10.2174/157341208785161308 |
0.342 |
|
| Show low-probability matches. |